(Q36153174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Richard Eastell

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

David Kendler

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ian Reid

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

4

Silvano Adami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

18

Jose Zanchetta

1 reference

16 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

5

Steven Boonen

1 reference

16 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

11

Andreas Grauer

1 reference

16 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

Matthew Austin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yu-Ching Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Douglas C Bauer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gerolamo Bianchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Michael A Bolognese

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Claus Christiansen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Federico Hawkins

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Beatriz Oliveri

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ethel S Siris

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Cristiano A F Zerbini

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Cesar Libanati

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Steven R Cummings

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

FREEDOM Trial

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Eric Vittinghoff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Research

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

687-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

Denosumab and bisphosphonates: different mechanisms of action and effects.

16 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Monitoring osteoporosis treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Denosumab in postmenopausal women with low bone mineral density

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Osteoclast differentiation and activation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Random-effects models for longitudinal data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Estimating the proportion of treatment effect explained by a surrogate marker.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

A method to assess the proportion of treatment effect explained by a surrogate endpoint

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Antifracture efficacy of antiresorptive agents are related to changes in bone density.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3415619

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22095631

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22095631

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22095631

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/JBMR.1472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22095631%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

22095631

1 reference